Cargando…

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease

BACKGROUND: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both adipocytes and macrophages. Recent studies have shown that FABP4 is secreted from adipocytes and that FABP4 level is associated with obesity, insulin resistance, and atherosclerosis. However, little...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furuhashi, Masato, Ishimura, Shutaro, Ota, Hideki, Hayashi, Manabu, Nishitani, Takahiro, Tanaka, Marenao, Yoshida, Hideaki, Shimamoto, Kazuaki, Hotamisligil, Gökhan S., Miura, Tetsuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213139/ https://www.ncbi.nlm.nih.gov/pubmed/22102888 http://dx.doi.org/10.1371/journal.pone.0027356

Ejemplares similares

Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation
por: Ota, Hideki, et al.
Publicado: (2012)

Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction
por: Okazaki, Yusuke, et al.
Publicado: (2014)

Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury
por: Fuseya, Takahiro, et al.
Publicado: (2017)

Lipid Chaperones and Metabolic Inflammation
por: Furuhashi, Masato, et al.
Publicado: (2011)

Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population
por: Fuseya, Takahiro, et al.
Publicado: (2014)

Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population
por: Ishimura, Shutaro, et al.
Publicado: (2013)

Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters
por: Furuhashi, Masato, et al.
Publicado: (2016)

Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
por: Furuhashi, Masato, et al.
Publicado: (2015)

Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals
por: Tanaka, Marenao, et al.
Publicado: (2022)

Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury
por: Ishimura, Shutaro, et al.
Publicado: (2014)

Reply to the comments of Naharci et al. on “Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals”
por: Tanaka, Marenao, et al.
Publicado: (2022)

Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor
por: Furuhashi, Masato, et al.
Publicado: (2016)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study
por: Saito, Norie, et al.
Publicado: (2021)

Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication
por: Furuhashi, Masato, et al.
Publicado: (2022)

Differential regulation of hypoxanthine and xanthine by obesity in a general population
por: Furuhashi, Masato, et al.
Publicado: (2020)

Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria
por: Tanaka, Marenao, et al.
Publicado: (2020)

Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without Medication
por: Furuhashi, Masato, et al.
Publicado: (2022)

Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
por: Furuhashi, Masato, et al.
Publicado: (2017)

Increased LDL-cholesterol level is associated with deterioration of renal function in males
por: Osanami, Arata, et al.
Publicado: (2022)

High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects
por: Higashiura, Yukimura, et al.
Publicado: (2021)

Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects
por: Takahashi, Satoko, et al.
Publicado: (2021)

Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10‐Year Period in Both Male and Female Subjects
por: Higashiura, Yukimura, et al.
Publicado: (2021)

A Predominant Role for Parenchymal c-Jun Amino Terminal Kinase (JNK) in the Regulation of Systemic Insulin Sensitivity
por: Vallerie, Sara N., et al.
Publicado: (2008)

Correction: A Predominant Role for Parenchymal c-Jun Amino Terminal Kinase (JNK) in the Regulation of Systemic Insulin Sensitivity
por: Vallerie, Sara N., et al.
Publicado: (2009)

A Case of Crescentic Glomerulonephritis Complicated with Hypocomplementemic Urticarial Vasculitis Syndrome and ANCA-Associated Vasculitis
por: Tanaka, Marenao, et al.
Publicado: (2017)

Low urine pH predicts new onset of diabetes mellitus during a 10‐year period in men: BOREAS‐DM1 study
por: Higashiura, Yukimura, et al.
Publicado: (2020)

Small-Molecule Inhibitors of PKR Improve Glucose Homeostasis in Obese Diabetic Mice
por: Nakamura, Takahisa, et al.
Publicado: (2014)

Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19
por: Furuhashi, Masato, et al.
Publicado: (2020)

Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease
por: Miyamori, Daisuke, et al.
Publicado: (2023)

Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Internal Thoracic Artery and Diseased Coronary Artery
por: Numaguchi, Ryosuke, et al.
Publicado: (2019)

Antiatherosclerotic Phenotype of Perivascular Adipose Tissue Surrounding the Saphenous Vein in Coronary Artery Bypass Grafting
por: Mikami, Takuma, et al.
Publicado: (2021)

High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population
por: Higashiura, Yukimura, et al.
Publicado: (2022)

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
por: Furuhashi, Masato
Publicado: (2019)

Endoplasmic Reticulum Stress in Diabetic Hearts Abolishes Erythropoietin-Induced Myocardial Protection by Impairment of Phospho–Glycogen Synthase Kinase-3β–Mediated Suppression of Mitochondrial Permeability Transition
por: Miki, Takayuki, et al.
Publicado: (2009)

Impact of ER Protein Homeostasis on Metabolism
por: Yalcin, Abdullah, et al.
Publicado: (2013)

Fatty Acid Binding Protein 4 Deficiency Protects against Oxygen-Induced Retinopathy in Mice
por: Saint-Geniez, Magali, et al.
Publicado: (2014)

Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats
por: Kuno, Atsushi, et al.
Publicado: (2020)

Evaluation of a 3D system based on a high-quality flat screen and polarized glasses for use by surgical assistants during robotic surgery
por: Tanaka, Kazushi, et al.
Publicado: (2014)

Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells
por: Yamamoto, Tokunori, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jdcucgj1douhe09e0vnd1rhbvf